KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Amortizatization of Intangibles: 2016-2024

Historic Amortizatization of Intangibles for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to $95.0 million.

  • Moderna's Amortizatization of Intangibles fell 19.05% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.0 million, marking a year-over-year decrease of 23.96%. This contributed to the annual value of $95.0 million for FY2024, which is 55.74% up from last year.
  • Latest data reveals that Moderna reported Amortizatization of Intangibles of $95.0 million as of FY2024, which was up 55.74% from $61.0 million recorded in FY2023.
  • Moderna's Amortizatization of Intangibles' 5-year high stood at $95.0 million during FY2024, with a 5-year trough of -$54.0 million in FY2021.
  • Its 3-year average for Amortizatization of Intangibles is $41.7 million, with a median of $61.0 million in 2023.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first tumbled by 440.00% in 2021, then spiked by 296.77% in 2023.
  • Over the past 5 years, Moderna's Amortizatization of Intangibles (Yearly) stood at -$10.0 million in 2020, then plummeted by 440.00% to -$54.0 million in 2021, then soared by 42.59% to -$31.0 million in 2022, then surged by 296.77% to $61.0 million in 2023, then skyrocketed by 55.74% to $95.0 million in 2024.